TLR7 and colorectal carcinoma: Furthermore, it has been demonstrated by other researchers that the persistent activation of TLR7, which is expressed by multipotent CD133+ colon cancer‐initiating cells and tumor cells from CRC, sustains the inflammatory response, facilitates resistance to apoptosis, and encourages the growth of new tumors.286